242 related articles for article (PubMed ID: 29984389)
1. Polymorphisms of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36) associated with valproate-induced obesity in epileptic patients.
Bai X; Xu C; Wen D; Chen Y; Li H; Wang X; Zhou L; Huang M; Jin J
Psychopharmacology (Berl); 2018 Sep; 235(9):2665-2673. PubMed ID: 29984389
[TBL] [Abstract][Full Text] [Related]
2. Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid.
Li H; Wang X; Zhou Y; Ni G; Su Q; Chen Z; Chen Z; Li J; Chen X; Hou X; Xie W; Xin S; Zhou L; Huang M
Int J Neuropsychopharmacol; 2015 Mar; 18(7):pyv021. PubMed ID: 25740917
[TBL] [Abstract][Full Text] [Related]
3. Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy.
Kanemura H; Sano F; Maeda Y; Sugita K; Aihara M
Seizure; 2012 Sep; 21(7):496-500. PubMed ID: 22694920
[TBL] [Abstract][Full Text] [Related]
4. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain.
Noai M; Soraoka H; Kajiwara A; Tanamachi Y; Oniki K; Nakagawa K; Ishitsu T; Saruwatari J
Acta Neurol Scand; 2016 Mar; 133(3):216-23. PubMed ID: 26223287
[TBL] [Abstract][Full Text] [Related]
6. [Association of both peroxisome proliferator-activated receptor, gene-gene interactions and the body mass index].
Luo WS; Guo ZR; Wu M; Chen Q; Zhou ZY; Yu H; Zhang LJ; Liu JC
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul; 33(7):740-5. PubMed ID: 22968028
[TBL] [Abstract][Full Text] [Related]
7. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Hamed SA; Fida NM; Hamed EA
Eur J Paediatr Neurol; 2009 May; 13(3):261-8. PubMed ID: 18586538
[TBL] [Abstract][Full Text] [Related]
8. CYP2C19 & UGT1A6 genetic polymorphisms and the impact on Valproic acid-induced weight gain in people with epilepsy: Prospective genetic association study.
Mani B; Nair PP; Sekhar A; Kamalanathan S; Narayan SK; Kesavan R
Epilepsy Res; 2021 Nov; 177():106786. PubMed ID: 34656038
[TBL] [Abstract][Full Text] [Related]
9. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
Sidhu HS; Srinivas R; Sadhotra A
Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
[TBL] [Abstract][Full Text] [Related]
10. Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the Chinese Han population.
Luo W; Guo Z; Wu M; Hao C; Hu X; Zhou Z; Zhou Z; Yao X; Zhang L; Liu J
J Epidemiol; 2013; 23(3):187-94. PubMed ID: 23545576
[TBL] [Abstract][Full Text] [Related]
11. SCN1A Polymorphisms and Haplotypes Are Associated With Valproic Acid Treatment Outcomes in Chinese Children With Epilepsy.
Zhu J; Lu J; Shen X; He Y; Xia H; Li W; Guo H; Zhang J; Fan X
Pediatr Neurol; 2023 Sep; 146():55-64. PubMed ID: 37451178
[TBL] [Abstract][Full Text] [Related]
12. Obesity and plasma concentrations of alpha-tocopherol and beta-carotene in epileptic girls treated with valproate.
Verrotti A; Greco R; Latini G; De Simone M; Chiarelli F
Neuroendocrinology; 2004 Mar; 79(3):157-62. PubMed ID: 15103229
[TBL] [Abstract][Full Text] [Related]
13. Correlation of MCT1 and ABCC2 gene polymorphisms with valproic acid resistance in patients with epilepsy on valproic acid monotherapy.
Chen J; Su Q; Qin J; Zhou Y; Ruan H; Chen Z; Chen Z; Li H; Zhou Y; Zhou S; Wang X; Zhou L; Huang M
Drug Metab Pharmacokinet; 2019 Jun; 34(3):165-171. PubMed ID: 30952578
[TBL] [Abstract][Full Text] [Related]
14. Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study.
Petty SJ; Kantor S; Lawrence KM; Berkovic SF; Collins M; Hill KD; Makovey J; Sambrook PN; O'Brien TJ; Wark JD
Epilepsia; 2014 Oct; 55(10):1551-7. PubMed ID: 25124647
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome among Chinese obese patients with epilepsy on sodium valproate.
Fang J; Chen S; Tong N; Chen L; An D; Mu J; Zhou D
Seizure; 2012 Oct; 21(8):578-82. PubMed ID: 22743100
[TBL] [Abstract][Full Text] [Related]
16. Weight change in monozygotic twins treated with valproate.
Klein KM; Hamer HM; Reis J; Schmidtke J; Oertel WH; Theisen FM; Hebebrand J; Rosenow F
Obes Res; 2005 Aug; 13(8):1330-4. PubMed ID: 16129714
[TBL] [Abstract][Full Text] [Related]
17. CD36 gene variants is associated with type 2 diabetes mellitus through the interaction of obesity in rural Chinese adults.
Zhang D; Zhang R; Liu Y; Sun X; Yin Z; Li H; Zhao Y; Wang B; Ren Y; Cheng C; Liu X; Liu D; Liu F; Chen X; Liu L; Zhou Q; Xiong Y; Xu Q; Liu J; Hong S; You Z; Hu D; Zhang M
Gene; 2018 Jun; 659():155-159. PubMed ID: 29572193
[TBL] [Abstract][Full Text] [Related]
18. Association of epilepsy, anti-epileptic drugs (AEDs), and type 2 diabetes mellitus (T2DM): a population-based cohort retrospective study, impact of AEDs on T2DM-related molecular pathway, and via peroxisome proliferator-activated receptor γ transactivation.
Tien N; Wu TY; Lin CL; Chu FY; Wang CCN; Hsu CY; Tsai FJ; Fang YJ; Lim YP
Front Endocrinol (Lausanne); 2023; 14():1156952. PubMed ID: 37334286
[TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide polymorphisms of peroxisome proliferator-activated receptor-γ are associated with systemic lupus erythematosus in a Chinese Han population.
Ren DF; Zhang J
Clin Exp Dermatol; 2016 Jul; 41(5):541-6. PubMed ID: 27324555
[TBL] [Abstract][Full Text] [Related]
20. Association of SCN1A, SCN2A, and UGT2B7 Polymorphisms with Responsiveness to Valproic Acid in the Treatment of Epilepsy.
Lu Y; Su Q; Li M; Dayimu A; Dai X; Wang Z; Che F; Xue F
Biomed Res Int; 2020; 2020():8096235. PubMed ID: 32185219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
